Professional Documents
Culture Documents
Definition
Abrupt sustained decline in GFR Rising serum urea and creatinine Loss of water and salt homeostasis Life threatening metabolic sequelae Occurs over hours or days Incidence approximately 140 p.m.p. per year 5% of all surgical and medical admissions
Subtypes
Acute or acute on chronic Single organ or multi-organ failure Oliguric or polyuric Mild or severe
Aetiology
Pre-renal ARF Intrinsic ARF Post-renal ARF
Pre-renal ARF
Reversible fall in GFR due to renal hypoperfusion Hypovolaemia Haemorrhage, burns, GI fluid loss, renal fluid loss Hypotension Cardiogenic shock, sepsis Renal hypoperfusion renal vasoconstriction, drugs, liver disease, renal vascular disease
Renal ARF
Disease of the renal parenchyma
ATN
Ischaemia, direct toxicity, myoglobin, sepsis
Vascular disease
Vasculitis, atheroemboli, infarction
Diseases of glomeruli/arterioles
RPGN, myeloma, HUS, vasculitis, SLE
Tubulo-interstitial nephritis
Drug related, paraneoplastic
Post-renal ARF
Renal failure secondary to urinary tract obstruction
Ureteric
Calculi, carcinoma, retroperitoneal fibrosis, stricture
Bladder neck
prostatic hypertrophy/malignancy, carcinoma, neuropathy, blocked catheter
Prevention
Identify at risk patients
pre-existing CRF, diabetes, jaundice, myeloma, elderly
(140-age in years) x weight in kg serum creatinine (mol/L) (corrected for males x 1.23, females x 1.04)
Principles of investigation
Acute or acute on chronic? Exclude volume depletion Exclude renal tract obstruction Exclude major vascular occlusion Exclude renal parenchymal disease other than ATN
History
When did it start? What was the baseline renal function?
Pre -existing medical conditions
Examination
Current volume status
Skin turgor, oedema, lung bases, heart sounds, central pressures, blood pressure
Investigations
Laboratory
U+Es, Bone, Glucose, Urate, Bicarbonate Urine urea, sodium, creatinine, protein FBC, Clotting, ESR Urine microscopy, MSU, blood cultures CRP, ANA, ANCA, anti GBM, myeloma screen
Investigation
Radiology
Plain abdomen, renal U/S, IVU, CT scanning, renal angiography, isotope renography
Renal biopsy
Treatment
Correct renal perfusion
Optimise volume status Inotropes ( dopamin 3 ug/kgBB/jam )
Treatment
Make the patient safe Hyperkalaemia
Volume overload Uraemia Acidosis
Specific treatments
Antibiotics, steroids
Methods of treatment
DRUG Calcium Gluconate Glucose + Insulin IV Na Bicarbonate Ventolin Nebuliser Resonium DOSE DURATION 30 minutes 1 - 4 hours 1 - 8 hours 1 - 4 hours days
10 ml of 10%
50 ml 50% + 8U 1l of 1.4% 5 ml 30 - 60 g (po/pr)
Bendrofluazide
5mg
days
Dialysis
Acute intermittent haemodialysis Continuous dialysis treatments Peritoneal dialysis
Outcome
Full recovery Partial recovery No recovery - progress to ESRF Death